sitagliptin vs semaglutide PDF) Efficacy and safety of once‐weekly versus once‐daily as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial Efficacy and Safety of Once-Weekly

She is going to be your best cheerleader and your most reliable coach

( ii ) If an MVP includes a QCDR measure, it is not required to be reported by a QCDR other than the measure owner

Understanding how gastric motility adapts during GLP-1 therapy matters for both efficacy and tolerability

With the popularity of GLP-1 agonists ever-increasing and over 150 GLP-1 drug candidates in development [3], the field is continually expanding, most recently into oncology and obesity-related cancers.[4] While most approved GLP-1RAs require subcutaneous injection, substantial work is being undertaken to move toward oral GLP-1 therapies [5], such as Rybelsus which was the first oral GLP-1RA approved by the FDA in 2019

Rizzo A, Cusmai A, Acquafredda S, Giovannelli F, Rinaldi L, Misino A, et al